Back to Results

Terrascend Corp (TSNDF)

TerrAscend Corp. is a common stock listing on OTC Markets for a healthcare company focused on cannabis. Through its operations in Canada and the United States, the company cultivates, produces, and sells cannabis products, including vaporizables, concentrates, topicals, flowers, tinctures, and edibles. Its portfolio includes brands such as Kind Tree Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, and Cookies. TerrAscend also operates retail dispensaries under the Apothecarium name and serves both medical patients and adult-use consumers across North America. Incorporated in 2017, the company is headquartered in Mississauga, Canada.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-TSND.F
$0.52
9.2% Upside
Fair
$1.50
215.3% Upside
Bargain
Good
0.0%
2.4x
0.7x
172.9 M
366.8 M
56.3%
71.4%
-5.0
-60.7%
Valuation • Fair Value

Terrascend Corp (OTC-TSND.F) Fair Value by Valuation Model

Review the available estimates for Terrascend Corp (OTC-TSND.F), including EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.52

Estimated upside of 9.2% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

EPV Fair Value

$0.29

Earnings power value estimate.

Comps Fair Value

$0.56

Comparable-company valuation reference.

Analyst Price Target

$1.50

Analysts imply upside of 215.3%.

How to read these valuation models

Use the 5 available valuation references for Terrascend Corp (OTC-TSND.F) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Terrascend Corp (OTC-TSND.F)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

263.9 M

Current operating scale indicator.

Revenue Forecast

266.7 M

Forward revenue estimate.

EBITDA

60.833 M

Current operating profitability reference.

EBITDA Forecast

69 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Terrascend Corp (OTC-TSND.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Terrascend Corp (OTC-TSND.F)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-3.10

No elevated caution signal from this screen.

Altman Z-Score

-5.0

Lower score that deserves closer risk review.

FCF / Net Income

-60.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Terrascend Corp (OTC-TSND.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Terrascend Corp (OTC-TSND.F)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Terrascend Corp (OTC-TSND.F). No upcoming dividend amount or event date is currently available.

Stock Forecast • Technical Outlook

Terrascend Corp (OTC-TSND.F) Stock Forecast & Technical Outlook

Review Terrascend Corp (OTC-TSND.F) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Terrascend Corp (OTC-TSND.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Terrascend Corp (OTC-TSND.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Terrascend Corp (OTC-TSND.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Terrascend Corp (OTC-TSND.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Terrascend Corp (OTC-TSND.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Terrascend Corp (OTC-TSND.F)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Terrascend Corp (OTC-TSND.F) has a Strong Buy consensus, with 2 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 0
Sell 0
FAQ • Fast Investor Answers

Terrascend Corp (OTC-TSND.F) Stock FAQ

Data-supported answers about Terrascend Corp (OTC-TSND.F), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.52
Estimated upside 9.2%
Valuation Rating
Undervalued
Estimated upside of 9.2%
Analyst Target
$1.50
Implied upside 215.3%
Financial Health
Good
Current financial-health read

The current fair value estimate for Terrascend Corp (OTC-TSND.F) is $0.52. This implies an estimated upside of 9.2% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 9.2% versus the current market price.

The available analyst price target for Terrascend Corp (OTC-TSND.F) is $1.50. The analyst target implies estimated upside of 215.3%.

The current financial health read for Terrascend Corp (OTC-TSND.F) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Terrascend Corp (OTC-TSND.F).

The current market capitalization listed for Terrascend Corp is 172.9 M.

The current enterprise value listed for Terrascend Corp is 366.8 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Terrascend Corp is OTC-TSND.F, and the stock is listed on OTC Markets.

Terrascend Corp (OTC-TSND.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Terrascend Corp is 56.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Terrascend Corp is 71.4%. Free float helps investors understand how much of the share base is available for public trading.

Similar Pharmaceuticals Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

LLY NYSE Eli Lilly and Company Fair Value Fair Market Cap 1,215.6 B
JNJ NYSE Johnson & Johnson Fair Value Fair Market Cap 655.6 B
MRK NYSE Merck & Company Inc Fair Value Fair Market Cap 362.2 B
NVS NYSE Novartis AG ADR Fair Value Fair Market Cap 310 B
NVO NYSE Novo Nordisk A/S Fair Value Bargain Market Cap 179.5 B
PFE NYSE Pfizer Inc Fair Value Fair Market Cap 170.3 B
BMY NYSE Bristol-Myers Squibb Company Fair Value Fair Market Cap 129 B
SNY NASDAQ Sanofi ADR Fair Value Undervalued Market Cap 113.6 B
GSK NYSE GSK plc DRC Fair Value Undervalued Market Cap 101.9 B
TAK NYSE Takeda Pharmaceutical Co Ltd ADR Fair Value Fair Market Cap 69.723 B
TEVA NYSE Teva Pharma Industries Ltd ADR Fair Value Fair Market Cap 48.75 B
HLN NYSE HALEON PLC ADR Fair Value Undervalued Market Cap 40.368 B
RPRX NASDAQ Royalty Pharma Plc Fair Value Fair Market Cap 38.751 B
ZTS NYSE Zoetis Inc Fair Value Undervalued Market Cap 33.93 B
VTRS NASDAQ Viatris Inc Fair Value Fair Market Cap 21.789 B
JAZZ NASDAQ Jazz Pharmaceuticals PLC Fair Value Undervalued Market Cap 14.59 B
RDY NYSE Dr. Reddy’s Laboratories Ltd ADR Fair Value Fair Market Cap 11.996 B
ELAN NYSE Elanco Animal Health Fair Value Overvalued Market Cap 11.831 B
CORT NASDAQ Corcept Therapeutics Incorporated Fair Value Fair Market Cap 7.834 B
AXSM NASDAQ Axsome Therapeutics Inc Fair Value Undervalued Market Cap 6.827 B